Osteogenic Repair from Human Pluripotent Stem Cells
人类多能干细胞的成骨修复
基本信息
- 批准号:8685947
- 负责人:
- 金额:$ 35.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAreaAscorbic AcidAutologousBiologyBlood VesselsBone DevelopmentBone DiseasesBone MarrowBone RegenerationCell TherapyCellsClinicalComplexDefectDevelopmentDevelopmental BiologyDevelopmental GeneDexamethasoneEnvironmentFractureFracture HealingGene ExpressionGeneticGrowthHealedHistologyHumanImplantInjuryMediatingMesenchymalMesodermModelingMorbidity - disease rateMusculoskeletalMusculoskeletal DiseasesOrthopedic Surgery proceduresOrthopedicsOsteoblastsOsteogenesisPathway interactionsPatientsPharmaceutical PreparationsPhenotypePluripotent Stem CellsPopulationProductionProteinsRNARegenerative MedicineReporterResearchRodentSignal PathwaySignal TransductionSirolimusSiteSourceStem Cell DevelopmentStem cellsStimulusStromal CellsSurfaceSystemTestingTimeTranscriptTranslatingTranslationsTraumaUndifferentiatedadult stem cellbasebiomechanical engineeringboneclinical practicedesignhealinghigh throughput screeninghuman embryonic stem cellhuman embryonic stem cell linehuman stem cellsimplantationimprovedin vitro Assayin vivoinduced pluripotent stem cellinnovationinsightmeetingsnovelnovel strategiesnovel therapeutic interventionosteogenicosteoprogenitor cellpromoterrecombinant human bone morphogenetic protein-2repairedscaffoldstemstem cell biologystem cell populationsubcutaneoustherapeutic developmenttissue regeneration
项目摘要
DESCRIPTION (provided by applicant): The development of novel therapeutic approaches to repair fractures and other bony defects remains a critical necessity to treat complex and non-healing orthopedic injuries. This proposal focuses on use of human embryonic stem cells (hESCs) and induced-Pluripotent Stem Cells (iPSCs) offer specific advantages for development of new therapies to improve bone formation and fracture healing. This proposal is designed to test the hypothesis that cells derived from hESCs and iPSCs serve as mesoderm progenitor cells with osteogenic potential and have the ability to repair non-union orthopedic fractures. These studies will pursue two complementary approaches. First, we will utilize an expression-reporter hESC line that we have generated that has the promoter RUNX2 (an early osteoblast developmental gene) to drive expression of the fluorescent protein, mCitrine (mCit). Identification and isolation of RUNX2/mCit+ these cells will allow us to define key signaling pathways that mediate the development of osteogenic cells. Specifically, osteoinductive including dexamethasone, ascorbic acid, rhFGF-9, rhBMP-2, Wnt3a and rapamycin will be used to stimulate RUNX2-mCit expression. The identification of mCit+ cells will us to identify similar populations of osteogeneic cells derived from iPSCs, eventually paving the way for the utilization of patient-specific (autologous) iPSC- based therapies. The second aim will utilize hESC and iPSC-derived mesenchymal stem/stromal cells (MSCs) and osteogenic cells to define the optimal phenotypic cell population and conditions for osteogenic growth and repair. We hypothesize that hESC- and iPSC-derived cells will have increased osteogenic potential compared to MSCs isolated from human bone marrow (BM-MSCs). Specifically, we will advance our preliminary studies that demonstrate that hESC/iPSC-derived MSC have more vascular inductive potential than BM-MSCs leading enhanced healing in vivo. Here, two in vivo osteogenic models will be evaluated: subcutaneous implantation of cells within scaffolds and a rodent fracture repair model with osteogenic cells locally implanted within scaffolds at the non-union fracture site. Together, this project combines expertise of research groups with proficiency in stem cell biology, orthopedic surgery, biomechanical engineering, bone biology, histology and osteogenic developmental biology. Successful completion of these studies will advance the use of human pluripotent stem cells to better define cellular and genetic mechanisms that mediate human bone development and translate these studies to stem cell-based repair of non-union orthopedic fractures.
描述(由申请人提供):开发新的治疗方法来修复骨折和其他骨缺陷仍然是治疗复杂和不可愈合的骨科损伤的关键。这项建议侧重于使用人类胚胎干细胞(HESCs)和诱导多能干细胞(IPSCs),为促进骨形成和骨折愈合的新疗法的开发提供了独特的优势。这一建议旨在验证一种假设,即来源于hESCs和ipSCs的细胞是具有成骨能力的中胚层前体细胞,并具有修复骨不连的能力。这些研究将采用两种相辅相成的方法。首先,我们将利用我们建立的具有启动子RUNX2(一种早期成骨细胞发育基因)的hESC系来驱动荧光蛋白mCitine(MCIT)的表达。鉴定和分离RUNX2/MCIT+这些细胞将使我们能够确定介导成骨细胞发育的关键信号通路。具体地说,包括地塞米松、抗坏血酸、重组人成纤维细胞生长因子-9、重组人骨形成蛋白-2、Wnt3a和雷帕霉素在内的成骨诱导剂将被用来刺激RUNX2-MCIT的表达。对MCIT+细胞的鉴定将使我们能够鉴定来自IPSC的相似群体的成骨细胞,最终为使用针对患者的(自体)IPSC疗法铺平道路。第二个目标将利用hESC和IPSC来源的间充质干细胞/基质细胞(MSCs)和成骨细胞来确定成骨生长和修复的最佳表型细胞群和条件。我们假设hESC和IPSC来源的细胞将比从人骨髓分离的MSCs(BM-MSCs)具有更强的成骨能力。具体地说,我们将推进我们的初步研究,证明hESC/IPSC来源的MSC比BM-MSCs具有更多的血管诱导潜力,从而促进体内愈合。在这里,将评估两种体内成骨模型:支架内细胞皮下植入和啮齿动物骨折修复模型,即在骨折不愈合处,将成骨细胞局部植入支架内。该项目结合了研究小组在干细胞生物学、整形外科手术、生物机械工程、骨生物学、组织学和成骨发育生物学方面的专业知识。这些研究的成功完成将推动人类多能干细胞的使用,以更好地确定介导人类骨骼发育的细胞和遗传机制,并将这些研究转化为基于干细胞的骨不连修复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dan S. Kaufman其他文献
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.
人免疫缺陷病毒重组包膜糖蛋白对体外免疫细胞功能的影响。
- DOI:
- 发表时间:
1987 - 期刊:
- 影响因子:4.3
- 作者:
M. R. Shalaby;M. R. Shalaby;J. Krowka;T. J. Gregory;T. J. Gregory;S. E. Hirabayashi;S. E. Hirabayashi;Susan M. McCabe;Susan M. McCabe;Dan S. Kaufman;Dan S. Kaufman;Daniel P. Stites;Arthur J. Ammann;Arthur J. Ammann - 通讯作者:
Arthur J. Ammann
Cellular and genetic advances in analysis of hematopoietic development from human embryonic stem cells
- DOI:
10.1016/j.bcmd.2006.10.069 - 发表时间:
2007-03-01 - 期刊:
- 影响因子:
- 作者:
Petter S. Woll;C.M. Cameron;Andrew Wilber;Jonathan L. Linehan;Dan S. Kaufman - 通讯作者:
Dan S. Kaufman
HIF hits Wnt in the stem cell niche
缺氧诱导因子在干细胞龛中攻击 Wnt
- DOI:
10.1038/ncb1010-926 - 发表时间:
2010-10-01 - 期刊:
- 影响因子:19.100
- 作者:
Dan S. Kaufman - 通讯作者:
Dan S. Kaufman
Transcriptional and Functional Activity of Hemangiosarcoma Support Bone Marrow
血管肉瘤支持骨髓的转录和功能活性
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Jong Hyuk Kim;Ashley J. Schulte;A. Sarver;M. Angelos;M. Frantz;Colleen L. Forster;Timothy D. O’Brien;Ingrid Cornax;M. Gerard;O’Sullivan;Nuojin Cheng;M. Lewellen;L. Oseth;Sunil Kumar;Susan;Bullman;C. Pedamallu;Sagar M. Goyal;Matthew Meyerson;C. Troy;Lund;J. Alfoldi;Matthew Breen;Kerstin Lindblad;E. Dickerson;Dan S. Kaufman;Jaime F. Modiano - 通讯作者:
Jaime F. Modiano
Transcriptional and Functional Activity of Canine Hemangiosarcoma to Support
犬血管肉瘤的转录和功能活性支持
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Jong Hyuk Kim;Ashley J. Schulte;A. Sarver;M. Angelos;M. Aric;Frantz;Colleen L. Forster;Timothy D. O’Brien;Ingrid Cornax;M. Gerard;O’Sullivan;Nuojin Cheng;M. Lewellen;L. Oseth;Sunil Kumar;Susan;Bullman;C. Pedamallu;Sagar M. Goyal;Matthew Meyerson;C. Troy;Lund;J. Alfoldi;Kerstin Lindblad;Matthew Breen;E. Dickerson;Dan S. Kaufman;Jaime F. Modiano - 通讯作者:
Jaime F. Modiano
Dan S. Kaufman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dan S. Kaufman', 18)}}的其他基金
Identification of Novel Regulators of Natural Killer Cell Activity
自然杀伤细胞活性的新型调节剂的鉴定
- 批准号:
10112574 - 财政年份:2020
- 资助金额:
$ 35.21万 - 项目类别:
Identification of Novel Regulators of Natural Killer Cell Activity
自然杀伤细胞活性的新型调节剂的鉴定
- 批准号:
10312800 - 财政年份:2020
- 资助金额:
$ 35.21万 - 项目类别:
Osteogenic Repair from Human Pluripotent Stem Cells
人类多能干细胞的成骨修复
- 批准号:
8293086 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Osteogenic Repair from Human Pluripotent Stem Cells
人类多能干细胞的成骨修复
- 批准号:
8490346 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Osteogenic Repair from Human Pluripotent Stem Cells
人类多能干细胞的成骨修复
- 批准号:
9268921 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
Osteogenic Repair from Human Pluripotent Stem Cells
人类多能干细胞的成骨修复
- 批准号:
8158970 - 财政年份:2011
- 资助金额:
$ 35.21万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Research Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Major Research Instrumentation
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
Postdoctoral Fellowship: OPP-PRF: Tracking Long-Term Changes in Lake Area across the Arctic
博士后奖学金:OPP-PRF:追踪北极地区湖泊面积的长期变化
- 批准号:
2317873 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 35.21万 - 项目类别:
Standard Grant